Fluorine in PDB 8ptr: Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R

Enzymatic activity of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R

All present enzymatic activity of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R:
3.1.1.23;

Protein crystallography data

The structure of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R, PDB code: 8ptr was solved by S.Butini, J.Benz, U.Grether, L.Leibrock, A.Papa, S.Maramai, G.Carullo, S.Federico, A.Grillo, B.Di Guglielmo, S.Lamponi, S.Gemma, G.Campiani, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 73.81 / 1.73
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 90.883, 126.5, 60.177, 90, 90, 90
R / Rfree (%) 19.2 / 21

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R (pdb code 8ptr). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R, PDB code: 8ptr:

Fluorine binding site 1 out of 1 in 8ptr

Go back to Fluorine Binding Sites List in 8ptr
Fluorine binding site 1 out of 1 in the Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Complex Crystal Structure of Mutant Human Monoglyceride Lipase with Compound 5R within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F401

b:45.8
occ:1.00
F38 A:EFH401 0.0 45.8 1.0
C34 A:EFH401 1.4 45.2 1.0
C33 A:EFH401 2.3 45.0 1.0
C35 A:EFH401 2.3 44.9 1.0
CD2 A:LEU214 3.4 36.4 1.0
C A:LEU213 3.4 29.1 1.0
O A:LEU213 3.5 29.4 1.0
N A:LEU214 3.5 28.9 1.0
CB A:ALA151 3.6 47.2 1.0
C36 A:EFH401 3.6 44.9 1.0
C32 A:EFH401 3.6 45.4 1.0
CA A:LEU214 3.7 30.0 1.0
CB A:LEU213 3.7 28.0 1.0
CG2 A:VAL217 3.8 28.1 1.0
CG A:LEU214 3.9 34.7 1.0
C37 A:EFH401 4.1 45.1 1.0
CA A:LEU213 4.2 27.8 1.0
CB A:LEU214 4.4 31.7 1.0
CA A:ALA151 4.4 46.9 1.0
CB A:VAL217 4.5 28.1 1.0
O A:GLY210 4.6 31.4 1.0
O A:LEU150 4.6 40.0 1.0
CD1 A:LEU148 4.8 30.4 1.0
C31 A:EFH401 4.9 45.7 1.0
C A:LEU214 4.9 29.2 1.0
O30 A:EFH401 5.0 44.8 1.0

Reference:

S.Butini, U.Grether, K.M.Jung, A.Ligresti, M.Allara, A.G.J.Postmus, S.Maramai, S.Brogi, A.Papa, G.Carullo, D.Sykes, D.Veprintsev, S.Federico, A.Grillo, B.Di Guglielmo, A.Ramunno, A.F.Stevens, D.Heer, S.Lamponi, S.Gemma, J.Benz, V.Di Marzo, M.Van Der Stelt, D.Piomelli, G.Campiani. Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization. J.Med.Chem. 2024.
ISSN: ISSN 0022-2623
PubMed: 38241614
DOI: 10.1021/ACS.JMEDCHEM.3C01278
Page generated: Fri Aug 2 22:21:18 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy